Skip to content
HealthTech Series B Founded 2014

LifeLens

LifeLens Technologies develops an advanced physiological monitoring platform that provides comprehensive, real-time and retrospective health data through a compact wearable device. The FDA-cleared platform monitors multiple signals simultaneously, including ECG, SpO2, heart rate, heart rate variability, skin temperature, respiration rate, activity level, body position, step count, and gait analysis. Designed for…

📍 Warminster, United States · Disease Self Management,

Funding snapshot

Last roundSeries B
Amount$15M
Date4 November 2025
Total raised$40M
Team size74

About

LifeLens Technologies develops an advanced physiological monitoring platform that provides comprehensive, real-time and retrospective health data through a compact wearable device. The FDA-cleared platform monitors multiple signals simultaneously, including ECG, SpO2, heart rate, heart rate variability, skin temperature, respiration rate, activity level, body position, step count, and gait analysis. Designed for both defense and healthcare applications, the device is engineered for wearability and durability in tactical environments where rings and watches are impractical, and has been deployed by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). The platform delivers secure connectivity and data visualization for diagnostic, disease management, and treatment purposes. Founded in 2014 and headquartered in Warminster, United States, the company has raised approximately $39.7 million at the Series B stage.

Business model

Wearable Technology > Health and Wellness Devices > Cardiac,

Disease Self Management > Cardiac and Vascular Disorders > Monitoring > Heart Health > Device,

Healthcare IT > Provider > Clinical Operations > Decision Support > Diagnosis > Differential Diagnosis > Diagnostics > Devices and platform > Cardiology,

Cardiac and Vascular Disorders > Medical Devices > Screening Devices > Cardiac Diagnostic > Electrodiagnostic Testing (ECG) > Clinic Based

Institutional investors

Paragon Equity Partners Brightstone Venture Capital

Latest coverage

No articles yet.

Raising like LifeLens?

Analyze your pitch deck before your next raise.

Analyze My Deck →